|Oppenheimer & Co.||Leland Gershell|
|RBC Capital Markets||Gregory J. Renza, M.D.|
Avalo Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding the Company’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Avalo or its management. Avalo does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.